A close collaboration between Mayo Clinic researchers and a venture-backed startup focusing on prostate cancer is breaking new ground in the search for genetic biomarkers capable of predicting whether ...
John H. Weston has been appointed COO and executive vice president of the Prostate Cancer Foundation. Here are three things to know about Mr. Weston. 1. Most recently, he was chairman of the public ...
PSMA Alpha-PET DoubLET licensing provides Perspective with a strongly differentiated prostate cancer program SEATTLE, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or ...
QUESTION: I'm a guy in my late 40s and trying to pay more attention to my health. But I'm confused about whether I should be screened for prostate cancer. Can you help? ANSWER: The importance of all ...
Existing screening protocols in place are failing to identify patients who might be carriers of a genetic mutation that is linked to certain cancers, according to Mayo Clinic researchers. Both ...
The prostate is a small gland in males that aids in reproduction. Prostate cancer is one the most common types of cancer, and when it's detected early, often by a simple blood test, it has the best ...
Mayo Clinic announced the discovery of a molecule – B7-H3 - that can be used "to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery." We'll ...
A groundbreaking, hour-long procedure using electrical currents to eliminate hard-to-reach prostate tumors is providing renewed hope for thousands of men with prostate cancer. Known as the "Nanoknife" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback